HW
JAZZ icon

Hancock Whitney’s Jazz Pharmaceuticals JAZZ Stock Holding History

Hancock Whitney’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$898K Buy
4,421
+72
+2% +$12.6K 0.02% 450
2025
Q4 		$739K Buy
4,349
+38
+0.9% +$5.83K 0.01% 474
2025
Q3 		$568K Buy
4,311
+57
+1% +$6.84K 0.01% 534
2025
Q2 		$451K Buy
4,254
+1,605
+61% +$174K 0.01% 584
2025
Q1 		$329K Buy
+2,649
New +$346K 0.01% 530
2022
Q3 		– Sell
-3,952
Closed -$617K – 631
2022
Q2 		$617K Sell
3,952
-1,941
-33% -$299K 0.02% 384
2022
Q1 		$918K Sell
5,893
-38,540
-87% -$5.59M 0.03% 338
2021
Q4 		$5.66M Sell
44,433
-1,050
-2% -$138K 0.18% 114
2021
Q3 		$5.92M Buy
45,483
+79
+0.2% +$11.9K 0.21% 100
2021
Q2 		$8.07M Sell
45,404
-26,302
-37% -$4.56M 0.26% 88
2021
Q1 		$11.8M Buy
71,706
+495
+0.7% +$81.5K 0.4% 61
2020
Q4 		$11.8M Sell
71,211
-994
-1% -$148K 0.39% 58
2020
Q3 		$10.3M Sell
72,205
-5,514
-7% -$684K 0.38% 66
2020
Q2 		$8.58M Buy
77,719
+14,434
+23% +$1.6M 0.33% 73
2020
Q1 		$6.31M Buy
63,285
+28,985
+85% +$3.75M 0.25% 109
2019
Q4 		$5.12M Buy
34,300
+696
+2% +$94.7K 0.17% 160
2019
Q3 		$4.31M Buy
33,604
+29,599
+739% +$3.97M 0.14% 193
2019
Q2 		$571K Buy
4,005
+17
+0.4% +$2.29K 0.02% 590
2019
Q1 		$570K Buy
3,988
+226
+6% +$29.5K 0.02% 590
2018
Q4 		$466K Buy
3,762
+77
+2% +$11.4K 0.02% 610
2018
Q3 		$620K Buy
+3,685
New +$634K 0.02% 599

Other funds holding JAZZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Hancock Whitney's JAZZ Position: Q1 2026 in Review

Hancock Whitney increased its Jazz Pharmaceuticals (JAZZ) stake by 1.7% in Q1 2026, buying an estimated $12.6K and bringing the position to 4,421 shares worth $898K. The position accounts for 0.02% of the portfolio, ranked #450.

Hancock Whitney first reported a position in JAZZ in Q3 2018 and has held it in 21 quarters since. The position peaked at $11.8M in Q1 2021. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

  • Hancock Whitney held 4,421 shares of Jazz Pharmaceuticals worth $898K as of Q1 2026.
  • Hancock Whitney bought 72 Jazz Pharmaceuticals shares in Q1 2026, an estimated $12.6K.
  • Jazz Pharmaceuticals made up 0.02% of Hancock Whitney's portfolio in Q1 2026, its #450 holding.
  • Hancock Whitney first reported a position in Jazz Pharmaceuticals in Q3 2018 and has held it in 21 quarters since.
  • Hancock Whitney's Jazz Pharmaceuticals position peaked at $11.8M in Q1 2021.
  • 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on Hancock Whitney's 13F filing for Q1 2026, filed 15 May 2026.